In a field where market timing and data subjectivity can shift the fine line between success and failure, superior technology can work to your advantage. To date, the ePRO landscape has been dominated by consumer electronics devices pressed into a service for which they were not created. The technology behind the Med-eMonitor System, however, was devised specifically for ePRO deployment. There are three major elements differentiate Med-eMonitor from current electronic diary solutions. First, the Med-eMonitor was built from scratch with hardware and firmware created specifically for use in clinical trials. PDA-based solutions require disabling or modifying the existing operating environment. And all the back-engineering in the world can't change that simple fact. Starting with a clean slate enables us to optimize screen size, button configuration, and GUI options, as well as greatly simplify the software programming environment. Second, our template approach to protocol programming puts study design in the hands of the trial's designers instead of arcane programmers. Its WYSIWYG web-based environment simplifies the design process and cuts weeks or months off the lead-time for fielding a trial. It also enables 24-hour turnaround times on revisions and tweaks to address nuances in the trial Finally, Med-eMonitor is built on Microsoft .NET architecture, which is unsurpassed in terms of data integration. Its native XML foundation—and the tools available for legacy conversion—yield a common digital language that can be understood and accepted across virtually all data systems past, present and future. In all, InforMedix breakthroughs cover a total of 29 patents—15 awarded and 14 pending—including pioneer patent rights in the area of dose-response data.